Mark D. Rekhter

Follow

Person

Carmel, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Triazolopyrazinone derivative useful as a human PDE1 inhibitor
- Patent number 10,138,244
- Issue date Nov 27, 2018
- Eli Lilly and Company
- Mark David Rekhter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PDE1 inhibitor
- Patent number 10,112,951
- Issue date Oct 30, 2018
- Eli Lilly and Company
- Mark David Rekhter
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PDE1 INHIBITOR
- Publication number 20180099973
- Publication date Apr 12, 2018
- Eli Lilly and Company
- Mark David REKHTER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRAZINONE DERIVATIVE USEFUL AS A HUMAN PDE1 INHIBITOR
- Publication number 20180057494
- Publication date Mar 1, 2018
- Eli Lilly and Company
- Mark David Rekhter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,2-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF KIDNEY DISORDERS
- Publication number 20170246166
- Publication date Aug 31, 2017
- Eli Lilly and Company
- Michael James Genin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDE1 INHIBITOR
- Publication number 20170233396
- Publication date Aug 17, 2017
- Eli Lilly and Company
- Cynthia Darshini JESUDASON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazole-Based Hmg-Coa Reductase Inhibitors
- Publication number 20080027088
- Publication date Jan 31, 2008
- WARNER-LAMBERT COMPANY, LLC
- Reynold Homan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE